Why cannabis company Althea (ASX:AGH) is storming higher today

The Althea Group Holdings Ltd (ASX:AGH) share price is pushing higher on Tuesday after the release of a market update…

| More on:
cannabis leaves on a rising line graph representing growth of ASX cannabis share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Althea Group Holdings Ltd (ASX: AGH) share price is storming higher on Tuesday morning.

At the time of writing, the medical cannabis company's shares are up 4.5% to 57 cents.

Why is the Althea share price storming higher?

Investors have been buying the company's shares this morning following the release of a market update.

According to the release, in November Althea achieved its highest monthly revenue of $847,499. This was driven by the company recording its highest number of new patients and new healthcare professionals (HCPs) per business day.

In light of this and thanks to an excellent start to December, management revealed that it is on track to deliver its biggest quarter to date.

How are its businesses performing?

The release explains that Althea Australia recorded an average of 41.71 new patients and 2.24 new HCPs per business day. This was driven partly by a strong rebound in Victoria following a long COVID-19 lockdown.

It led to its Australian operations posting $737,121 of unaudited revenue in November.

Management expects its Australian growth to normalise in the coming months as the country's economy continues to recover.

Over in the UK, the company reported 48% month on month growth. This led to unaudited revenue of $110,378 for November.

Althea continues to execute on its early mover advantage in the territory, with approximately half of its prescriptions generated from its wholly-owned subsidiary, MyAccess Clinics.

Althea CEO Josh Fegan said: "I recently relocated permanently to London with my family to oversee the growth of the Althea brand in the UK and EU. With our market access strategy starting to resonate with UK prescribers and regulatory headwinds well and truly behind us, it is great to see our many months of hard work beginning to pay off."

"Our established Australian business continues to perform strongly, and we are looking forward to entering 2021 with fantastic momentum," he added.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »